• Mashup Score: 7

    After tense discussion, the panel voted in favor of the drug, molnupiravir, although members expressed concerns about its use in pregnancy.

    Tweet Tweets with this article
    • Excellent news in the fight against #COVID while still digesting the reports about the #omicron variant. It seems 2022 will not be about the #vaccine war but the pill war as more and more #pharma companies get their COVID #pills approved. #digitalhealth https://t.co/07Q63NaM6Z